![Anne Kirby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Kirby
No más puestos en curso
Fortuna: - $ al 30/09/2023
Perfil
Anne Kirby served as the President, CEO, Secretary & Director at Regnum Corp.
from 2021 to 2023.
Prior to that, she was the Executive Vice President-Commercial & Operations at Vyera Pharmaceuticals LLC from 2018 to 2021.
Ms. Kirby received her undergraduate degree in 2002 and her MBA in 2004 from the University of Akron.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
REGNUM CORP.
-.--% | 11/04/2023 | 0 ( -.--% ) | - $ | 30/09/2023 |
Antiguos cargos conocidos de Anne Kirby.
Empresas | Cargo | Fin |
---|---|---|
REGNUM CORP. | Director Ejecutivo | 23/05/2023 |
Vyera Pharmaceuticals LLC
![]() Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2021 |
Formación de Anne Kirby.
University of Akron | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
REGNUM CORP. | Health Technology |
Empresas privadas | 1 |
---|---|
Vyera Pharmaceuticals LLC
![]() Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Anne Kirby